Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Open-label Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care

NCT02195817 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT02195817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02195817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Open-label Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care
Lead sponsor
H. Lundbeck A/S
Phase
Phase 4
Overall status
Terminated
Start date
August 31, 2014
Completion date
February 29, 2016
Enrollment
378 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence